Smartphone Mobile Applications in Enhancing Smoking Cessation Treatment in Current Smokers
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 65 |
Updated: | 10/19/2018 |
Start Date: | April 25, 2018 |
End Date: | December 31, 2018 |
Contact: | Jennifer Minnix |
Email: | jminnix@mdanderson.org |
Phone: | 713-792-0476 |
Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment - A Pilot Study
This trial studies how well smartphone mobile applications work in enhancing smoking
cessation treatment in current smokers. Smartphone mobile applications may help current
smokers quit smoking.
cessation treatment in current smokers. Smartphone mobile applications may help current
smokers quit smoking.
PRIMARY OBJECTIVES:
I. To test the acceptability and preliminary efficacy of a smartphone health application
(app), Kick Ash, which will incorporate brief behavioral activation versus (vs.) a relaxation
app, Breathe2Relax in a small randomized controlled trial of smokers with elevated depressive
symptoms.
OUTLINE: Participants are randomized to 1 of 2 groups.
GROUP I: Participants receive KickAsh smartphone mobile application designed to help the
learning of relaxation skills over 8 weeks.
GROUP II: Participants receive Breathe2Relax smartphone mobile application designed to help
improve mood and increase level of enjoyable activities over 8 weeks.
I. To test the acceptability and preliminary efficacy of a smartphone health application
(app), Kick Ash, which will incorporate brief behavioral activation versus (vs.) a relaxation
app, Breathe2Relax in a small randomized controlled trial of smokers with elevated depressive
symptoms.
OUTLINE: Participants are randomized to 1 of 2 groups.
GROUP I: Participants receive KickAsh smartphone mobile application designed to help the
learning of relaxation skills over 8 weeks.
GROUP II: Participants receive Breathe2Relax smartphone mobile application designed to help
improve mood and increase level of enjoyable activities over 8 weeks.
Inclusion Criteria:
- MD Anderson patient
- Current smoker (i.e., at least 5 cigarettes/day)
- Smoking for at least one year
- Carbon monoxide (CO) level of 5 ppm or greater, confirming smoking status
- Willing to set a quit date in the next 30 days
- Not engaged in smoking cessation treatment other than the MD Anderson Cancer Center
(MDACC) Tobacco Treatment Program
- Currently elevated depressive symptoms; (Patient Health Questionnaire [PHQ] 2 = or >
2)
- English speaking and ability to read and comprehend English
- Currently own an iOS mobile phone (iPhone) using iOS 9.0 or later and reports regular
use (at least weekly) of at least 1 iOS app
Exclusion Criteria:
- Any medical or psychiatric condition, illness, disorder, or concomitant medication
that could compromise participant safety or treatment, as determined by the principal
investigator or collaborator
- Subject considered by the investigator an unsuitable candidate for receipt of a
smoking cessation treatment or unstable to be followed up throughout the entire
duration of the study
We found this trial at
1
site
Houston, Texas 77030
Principal Investigator: Jennifer A. Minnix
Phone: 713-792-0476
Click here to add this to my saved trials